Illumine Investment Management, LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 2052970 POULSBO, WA

Back to UTHR Full portfolio

Position in UTHR

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$4,586,700

+$548,372 QoQ

Shares Held

7,735

-6.7% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

4.42%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Illumine Investment Management, LLC holds $6,405,667 across 3 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (71.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp This page	7,735	$4,586,700
2	NBIX	Neurocrine Biosciences Inc	9,632	$1,268,919
3	AMPH	Amphastar Pharmaceuticals, Inc.	28,078	$550,048

All Filings in UTHR

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,586,700	7,735	-6.7%	Shares	Sole	2026-05-04
2025-12-31	$4,038,328	8,288	-2.7%	Shares	Sole	2026-02-09
2025-09-30	$3,569,573	8,515	-1.6%	Shares	Sole	2025-11-04
2025-06-30	$2,487,301	8,656	+0.6%	Shares	Sole	2025-08-07
2025-03-31	$2,652,355	8,604	+0.7%	Shares	Sole	2025-04-22
2024-12-31	$3,015,370	8,546	—	Shares	Sole	2025-02-05
No filing history on record for this holder in this stock.